Corporate insider profile
Ali Behbahani Insider Trades
Latest reported as Director of CRISPR Therapeutics AG (CRSP).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$780,935.48
- Latest transaction
- Sep 17, 2026
Affiliated corporations
Reported company relationships
Transaction history
